OMID HLDGS (OMID) Stock Price, News & Analysis
Company Description
OMID HLDGS (OTC Link: OMID) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $2.0M.
OMID has gained 16.2% over the past year. Shares last traded at $0.0221.
This page collects what Stock Titan holds for OMID, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
OMID HLDGS (OMID) stock last closed at $0.0221. Over the past 12 months, the stock has gained 16.2%. At a market capitalization of $2.0M, OMID is classified as a micro-cap stock with approximately 96.3M shares outstanding.
Latest News
OMID HLDGS has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all OMID news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in OMID HLDGS (OMID) currently stands at 17.8 thousand shares, down 24.4% from the previous reporting period, representing 0.0% of the float. Since July 2025, short interest has decreased by 60.1%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for OMID HLDGS (OMID) currently stands at 1.0 days, down 89.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.3 days.
OMID Company Profile & Sector Positioning
OMID HLDGS (OMID) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing OMID often look at related companies in the same sector, including Endexx Corp (EDXC), Radient Tech (RDDTF), Isracann Biosciences (ISCNF), Cannapharmarx (CPMD), and Marijuana (MCOA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OMID's relative position within its industry.